Population
Diabetic patients
Design
Other
Authors
Loading...
May heighten thrombotic risk awareness in diabetes; leaves open whether PF4 drives events in vivo.
Diabetic patients exhibit increased release of platelet factor 4 during platelet aggregation, which may contribute to the pathogenesis of thromboembolic complications.
Chmielewski et al. (1970) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: